Position in BMY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$5,890,089
-$324,291 QoQ
Shares Held
102,223
-0.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#504
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glenview Trust Co holds $465,808,551 across 12 Drug Manufacturers - General names. BMY ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
188,484 | $226,073,382 | |
| 2 | ABBV |
AbbVie Inc.
|
422,207 | $106,244,168 | |
| 3 | MRK |
Merck & Co., Inc.
|
381,609 | $49,036,756 | |
| 4 | JNJ |
Johnson & Johnson
|
150,964 | $38,340,326 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
195,795 | $24,736,739 | |
| 6 | PFE |
Pfizer Inc
|
442,787 | $10,662,310 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
102,223 | $5,890,089 | |
| 8 | AMGN |
Amgen Inc
|
8,321 | $3,013,200 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,890,089 | 102,223 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $6,214,380 | 102,463 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $5,508,837 | 102,129 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,617,608 | 102,386 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,888,501 | 105,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,490,860 | 106,425 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $6,039,476 | 106,780 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $5,304,953 | 102,531 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,217,703 | 101,558 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,430,537 | 100,139 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,108,217 | 99,556 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,378,247 | 109,894 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,999,135 | 109,447 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,510,777 | 108,365 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $7,832,116 | 108,855 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,580,681 | 106,635 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $8,228,913 | 106,869 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $7,723,579 | 105,759 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,637,531 | 106,456 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,540,355 | 110,535 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,388,687 | 110,576 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $7,156,416 | 113,360 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,185,431 | 115,838 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $7,078,708 | 117,411 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,013,899 | 119,284 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $6,750,391 | 121,105 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||